Front Row Advisors’s Patterson-UTI PTEN Stock Holding History

Front Row Advisors’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-75	Closed	-$1	–	1085
2018 Q3	$1	Buy	+75	New	+$1.29K	﹤0.01%	925

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Front Row Advisors's PTEN Position: Q4 2018 in Review

Front Row Advisors sold out of Patterson-UTI (PTEN) in Q4 2018, closing a stake of 75 shares — an estimated $1 sold.

Front Row Advisors first reported a position in PTEN in Q3 2018 and held it in 1 quarter. The position peaked at $1 in Q3 2018. 317 funds tracked by Wall St. Rank hold PTEN as of Q4 2018.

Front Row Advisors reported no remaining Patterson-UTI position as of Q4 2018 after selling out during the quarter.
Front Row Advisors sold 75 Patterson-UTI shares in Q4 2018, an estimated $1.
Front Row Advisors first reported a position in Patterson-UTI in Q3 2018 and held it in 1 quarter.
Front Row Advisors's Patterson-UTI position peaked at $1 in Q3 2018.
317 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2018.

Based on Front Row Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.